Baylor College of Medicine: New COVID-19 Vaccine Candidate, Option for Low- To Mid-Income Countries
July 16, 2021
July 16, 2021
HOUSTON, Texas, July 16 (TNSJou) -- The Baylor College of Medicine issued the following news on July 15, 2021:
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effect ive against SARS-COV-2. These findings also show that it will be easy to produce at large scale and cost-effective, important aspects for vaccinating people worldwide, especially in low- to midd . . .
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effect ive against SARS-COV-2. These findings also show that it will be easy to produce at large scale and cost-effective, important aspects for vaccinating people worldwide, especially in low- to midd . . .